Chris Davis Viatris Inc Transaction History

Davis Selected Advisers

$18.6 Billion
Q3 2025

A detailed history of Chris Davis (Davis Selected Advisers) transactions in Viatris Inc stock. As of the latest transaction made, Davis Selected Advisers holds 69,345,645 shares of VTRS stock, worth $743 Million. This represents 3.68% of its overall portfolio holdings.

Number of Shares

69,345,645

Previous 66,375,520 4.47%

Holding current value

$743 Million

Previous $593 Million 15.82%

% of portfolio

3.68%

Previous 3.26%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$8.74 - $10.69 $26 Million - $31.8 Million	2,970,125 Added 4.47%	69,345,645 $687 Million
Q2 2025 Aug 08, 2025	BUY	$7.26 - $9.12 $10.4 Million - $13 Million	1,427,284 Added 2.2%	66,375,520 $593 Million
Q1 2025 May 12, 2025	BUY	$8.68 - $12.42 $20.6 Million - $29.5 Million	2,374,674 Added 3.8%	64,948,236 $566 Million
Q4 2024 Feb 07, 2025	SELL	$11.32 - $13.37 $834,329 - $985,422	-73,704 Reduced 0.12%	62,573,562 $779 Million
Q3 2024 Nov 08, 2024	BUY	$10.32 - $12.13 $52.7 Million - $62 Million	5,111,313 Added 8.88%	62,647,266 $727 Million
Q2 2024 Aug 07, 2024	BUY	$10.05 - $12.02 $709,067 - $848,059	70,554 Added 0.12%	57,535,953 $612 Million
Q1 2024 May 13, 2024	SELL	$11.27 - $13.53 $58.6 Million - $70.3 Million	-5,196,329 Reduced 8.29%	57,465,399 $686 Million
Q4 2023 Feb 12, 2024	SELL	$8.77 - $10.85 $12.3 Million - $15.2 Million	-1,402,057 Reduced 2.19%	62,661,728 $679 Million
Q3 2023 Nov 09, 2023	BUY	$9.59 - $11.35 $10.7 Million - $12.7 Million	1,115,630 Added 1.77%	64,063,785 $632 Million
Q2 2023 Aug 09, 2023	BUY	$9.02 - $10.29 $71.6 Million - $81.7 Million	7,939,147 Added 14.43%	62,948,155 $628 Million
Q1 2023 May 08, 2023	BUY	$9.2 - $12.26 $2.64 Million - $3.52 Million	287,401 Added 0.53%	55,009,008 $529 Million
Q4 2022 Feb 10, 2023	SELL	$8.72 - $11.56 $6.44 Million - $8.54 Million	-738,579 Reduced 1.33%	54,721,607 $609 Million
Q3 2022 Nov 10, 2022	SELL	$8.48 - $11.13 $50,549 - $66,345	-5,961 Reduced 0.01%	55,460,186 $473 Million
Q2 2022 Aug 11, 2022	SELL	$9.95 - $12.27 $11.9 Million - $14.7 Million	-1,200,143 Reduced 2.12%	55,466,147 $581 Million
Q1 2022 May 12, 2022	BUY	$9.81 - $15.4 $116 Million - $182 Million	11,797,639 Added 26.29%	56,666,290 $617 Million
Q4 2021 Feb 11, 2022	BUY	$12.09 - $14.68 $13.7 Million - $16.6 Million	1,132,856 Added 2.59%	44,868,651 $607 Million
Q3 2021 Nov 12, 2021	BUY	$13.25 - $15.13 $24.1 Million - $27.5 Million	1,815,574 Added 4.33%	43,735,795 $593 Million
Q2 2021 Aug 13, 2021	BUY	$12.97 - $16.15 $8.18 Million - $10.2 Million	630,642 Added 1.53%	41,920,221 $599 Million
Q1 2021 May 13, 2021	BUY	$13.59 - $18.54 $402 Million - $548 Million	29,562,572 Added 252.09%	41,289,579 $577 Million
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $168 Million - $220 Million	11,727,007 New	11,727,007 $220 Million

Others Institutions Holding VTRS

# of Institutions

1,136

Shares Held

966M

Call Options Held

7.74M

Put Options Held

2.47M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track Chris Davis's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis Selected Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Davis Selected Advisers and Chris Davis with notifications on news.

Account